FINANCING AGREEMENT dated as of June 30, 2022 among BLUEPRINT MEDICINES CORPORATION, as Borrower, CERTAIN SUBSIDIARIES OF BORROWER, as Guarantors, VARIOUS LENDERS FROM TIME TO TIME PARTY HERETO, AND TAO TALENTS, LLC, as Administrative AgentFinancing Agreement • August 2nd, 2022 • Blueprint Medicines Corp • Pharmaceutical preparations • New York
This FINANCING AGREEMENT, dated as of June 30, 2022, is entered into by and among BLUEPRINT MEDICINES CORPORATION, a Delaware corporation (“Company” or “Borrower”), and certain Subsidiaries of Borrower, as Guarantors, the Lenders from time to time party hereto, and TAO Talents, LLC (“TAO Talents”), as administrative agent for the Lenders (in such capacity, “Administrative Agent”).
ContractPurchase and Sale Agreement • August 2nd, 2022 • Blueprint Medicines Corp • Pharmaceutical preparations • New York
CERTAIN INFORMATION IN THIS DOCUMENT, MARKED BY [***], HAS BEEN EXCLUDED PURSUANT TO REGULATION S-K, ITEM 601(b)(10)(iv). SUCH EXCLUDED INFORMATION IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.
PURCHASE AND SALE AGREEMENT BY AND AMONG BLUEPRINT MEDICINES CORPORATION, GARNICH ADJACENT INVESTMENTS S.A.R.L. THE VARIOUS OTHER PURCHASERS FROM TIME TO TIME PARTY HERETO, AND GARNICH ADJACENT INVESTMENTS S.À.R.L., AS PURCHASER’S REPRESENTATIVE DATED...Purchase and Sale Agreement • August 2nd, 2022 • Blueprint Medicines Corp • Pharmaceutical preparations • New York
This PURCHASE AND SALE AGREEMENT, dated as of June 30, 2022 (this “Agreement”), is made and entered into by and among BLUEPRINT MEDICINES CORPORATION, a Delaware corporation (“Company” or “Seller”), GARNICH ADJACENT INVESTMENTS S.À.R.L., the other Purchasers from time to time party hereto, and GARNICH ADJACENT INVESTMENTS S.À.R.L. (“Garnich”), as representative for the Purchasers (in such capacity, “Purchaser’s Representative”).
